Page last updated: 2024-09-03

ae0047 and substance p

ae0047 has been researched along with substance p in 1 studies

Compound Research Comparison

Studies
(ae0047)
Trials
(ae0047)
Recent Studies (post-2010)
(ae0047)
Studies
(substance p)
Trials
(substance p)
Recent Studies (post-2010) (substance p)
230117,2892772,010

Protein Interaction Comparison

ProteinTaxonomyae0047 (IC50)substance p (IC50)
Substance-P receptorRattus norvegicus (Norway rat)0.0005
Substance-K receptorRattus norvegicus (Norway rat)0.2
Substance-K receptorHomo sapiens (human)0.2455
Substance-P receptorHomo sapiens (human)0.0011
Neuromedin-K receptorHomo sapiens (human)0.125
Substance-K receptorMesocricetus auratus (golden hamster)0.148

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishikawa, M; Okamura, T; Toda, N; Yoshida, K1

Other Studies

1 other study(ies) available for ae0047 and substance p

ArticleYear
AE0047, a new dihydropyridine Ca2+ entry blocker, inhibits the responses to adrenergic nerve stimulation and substance P in dog mesenteric arteries.
    European journal of pharmacology, 1992, Sep-10, Volume: 220, Issue:1

    Topics: Adrenergic alpha-Agonists; Animals; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Mesenteric Arteries; Nicardipine; Substance P; Sympathetic Nervous System; Tritium; Vasodilation

1992